首页 > 按专业查询名词 > 查询PubMed相关文献
名词信息
Pubmed相关的文献
ovarian carcinoma in situ相关文献:
Itaconic acid mediates crosstalk between macrophage metabolism and peritoneal tumors.
Weiss JM, Davies LC, Karwan M, Ileva L, Ozaki MK, Cheng RY, Ridnour LA, Annunziata CM, Wink DA, McVicar DW.
J Clin Invest. 2018 Aug 31;128(9):3794-3805. doi: 10.1172/JCI99169. Epub 2018 Jul 30.
PMID:29920191
"Early" Clear Cell Proliferations (Clear Cell Carcinoma in Situ) in Ovarian Endometriotic Cysts: Report of a Case Series With Recommendations for Terminology.
Karunadhas NS, Catherwood M, Stringfellow H, Arora R, McCluggage WG.
Am J Surg Pathol. 2025 May 6;49(9):901-908. doi: 10.1097/PAS.0000000000002415.
PMID:40326407
'STIC-like' lesions in ovarian low-grade serous carcinoma: a diagnostic pitfall.
Machuca-Aguado J, McCluggage WG.
Histopathology. 2023 Sep;83(3):489-492. doi: 10.1111/his.14967. Epub 2023 Jun 25.
PMID:37356967
Amplification of 11q13 in ovarian carcinoma.
Brown LA, Kalloger SE, Miller MA, Shih IeM, McKinney SE, Santos JL, Swenerton K, Spellman PT, Gray J, Gilks CB, Huntsman DG.
Genes Chromosomes Cancer. 2008 Jun;47(6):481-9. doi: 10.1002/gcc.20549.
PMID:18314909
Human Epidermal Growth Factor Receptor 2 Overexpression/Amplification in Primary Ovarian Endometrioid Carcinoma.
Bui CM, Oren A, Balzer B, Maluf H, Medeiros F.
Appl Immunohistochem Mol Morphol. 2024 May-Jun 01;32(5):222-228. doi: 10.1097/PAI.0000000000001194. Epub 2024 Apr 18.
PMID:38635473
Novel LAMC2 fusion protein has tumor-promoting properties in ovarian carcinoma.
Daisuke H, Kato H, Fukumura K, Mayeda A, Miyagi Y, Seiki M, Koshikawa N.
Cancer Sci. 2021 Dec;112(12):4957-4967. doi: 10.1111/cas.15149. Epub 2021 Nov 5.
PMID:34689384
Caveolin-1 expression in ovarian carcinoma is MDR1 independent.
Davidson B, Goldberg I, Givant-Horwitz V, Nesland JM, Berner A, Bryne M, Risberg B, Kopolovic J, Kristensen GB, Tropé CG, van de Putte G, Reich R.
Am J Clin Pathol. 2002 Feb;117(2):225-34. doi: 10.1309/u40r-1bn4-6kj3-bdg3.
PMID:11863219
Prognostic value of ALK overexpression and molecular abnormalities in high-grade serous ovarian carcinoma.
Gorczyński A, Miszewski K, Gager Y, Koch S, Pötschke J, Ugrinovski D, Gabert J, Pospieszyńska A, Wydra D, Duchnowska R, Szymanowski B, Cierniak S, Kruecken I, Neumann K, Mirkov K, Biernat W, Czapiewski P.
Cancer Biomark. 2023;38(1):17-26. doi: 10.3233/CBM-230117.
PMID:37522200
[Peritoneal carcinomatosis].
Coelho SS, Silva PM, Ramos J.
Acta Med Port. 1998 Jun;11(6):585-9.
PMID:9773541
Early and consistent overexpression of ADRM1 in ovarian high-grade serous carcinoma.
Jiang RT, Yemelyanova A, Xing D, Anchoori RK, Hamazaki J, Murata S, Seidman JD, Wang TL, Roden RBS.
J Ovarian Res. 2017 Aug 7;10(1):53. doi: 10.1186/s13048-017-0347-y.
PMID:28784174
© Copyright 2021 鸿泰茂源  版权所有All Rights Reserved京ICP备11040441号-3